N-(4-(((2,4-Diaminoquinazolin-6-yl)amino)methyl)phenethyl)-4-nitrobenzamide

ID: ALA4213904

Chembl Id: CHEMBL4213904

PubChem CID: 141482997

Max Phase: Preclinical

Molecular Formula: C24H23N7O3

Molecular Weight: 457.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(N)c2cc(NCc3ccc(CCNC(=O)c4ccc([N+](=O)[O-])cc4)cc3)ccc2n1

Standard InChI:  InChI=1S/C24H23N7O3/c25-22-20-13-18(7-10-21(20)29-24(26)30-22)28-14-16-3-1-15(2-4-16)11-12-27-23(32)17-5-8-19(9-6-17)31(33)34/h1-10,13,28H,11-12,14H2,(H,27,32)(H4,25,26,29,30)

Standard InChI Key:  NRZDHPATDCAABX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4213904

    ---

Associated Targets(non-human)

Cysteine protease falcipain-2 (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dihydrofolate reductase (1810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 457.49Molecular Weight (Monoisotopic): 457.1862AlogP: 3.29#Rotatable Bonds: 8
Polar Surface Area: 162.09Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.70CX Basic pKa: 7.41CX LogP: 3.27CX LogD: 2.96
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.32

References

1. Chen W, Huang Z, Wang W, Mao F, Guan L, Tang Y, Jiang H, Li J, Huang J, Jiang L, Zhu J..  (2017)  Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.,  25  (24): [PMID:29111368] [10.1016/j.bmc.2017.10.017]

Source